Detalhe da pesquisa
1.
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
Cancer
; 130(2): 287-299, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801052
2.
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications.
Eur J Haematol
; 112(6): 860-869, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294126
3.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer
; 129(17): 2637-2644, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354090
4.
Myelodysplastic syndromes with ring sideroblasts.
Hematol Oncol
; 41(4): 612-620, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794650
5.
Iron chelation therapy.
Eur J Haematol
; 110(5): 490-497, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708354
6.
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Am J Hematol
; 98(11): 1762-1771, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647134
7.
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Br J Haematol
; 196(3): 559-565, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636033
8.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877211
9.
Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors.
Hematol Oncol
; 39(3): 401-408, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617659
10.
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
Ann Hematol
; 100(8): 2005-2014, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388860
11.
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Ann Hematol
; 99(7): 1525-1530, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474619
12.
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
Eur J Haematol
; 105(3): 286-291, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365249
13.
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Haematologica
; 104(8): 1589-1596, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819917
14.
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Ann Hematol
; 98(10): 2329-2338, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31392461
15.
Home care of acute leukaemia patients: From active therapy to end-of-life and palliative care. The 3-year experience of a single centre.
Eur J Haematol
; 102(5): 424-431, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30801819
16.
Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.
Cancer
; 124(10): 2228-2237, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29499087
17.
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.
Ann Hematol
; 97(9): 1577-1580, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29675611
18.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222267
19.
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.
Am J Hematol
; 92(1): 82-87, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27770583
20.
Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy.
Ann Hematol
; 98(11): 2609-2611, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529281